2,386 results on '"Schirmacher P"'
Search Results
102. Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
103. Die Deutsche Gesellschaft für Pathologie – Ein Blick zurück nach vorne: Festvortrag anlässlich der 103. Jahrestagung der DGP, Frankfurt am Main, 13.06.2019
104. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury
105. Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays
106. Dimensional characterization of cadmium selenide nanocrystals via indirect Fourier transform evaluation of small-angle X-ray scattering data
107. The BRCA2 mutation status shapes the immune phenotype of prostate cancer
108. Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer
109. YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells
110. A Novel Variant (Asn177Asp) in SPTLC2 Causing Hereditary Sensory Autonomic Neuropathy Type 1C
111. Von der Paneldiagnostik zu umfassenden genomischen Analysen: Informationsüberfluss oder Zugewinn?
112. HER2 testing in gastric cancer diagnosis: insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany
113. Emerging Role of the Pathologist in Precision Medicine for HCC
114. Electronic correlation effects and the Coulomb gap at finite temperature
115. Harmonic Vibrational Excitations in Disordered Solids and the 'Boson Peak'
116. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis
117. Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria
118. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
119. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma
120. BRAF mutation testing in melanoma: results from a German observational multicenter study
121. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
122. Überwindung der Zugangsbarrieren in der molekularen onkologischen Diagnostik
123. SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy
124. Zentralisierte Molekulare Tumordiagnostik durch kommerzielle Anbieter: Konsequenzen für Patienten, Krankenversorgung und Forschung
125. Widespread expression of perilipin 5 in normal human tissues and in diseases is restricted to distinct lipid droplet subpopulations
126. The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation
127. Ethik und Rechtslage von humanen Biobanken
128. Das hepatozelluläre Karzinom – pathologische und molekularpathologische Diagnostik
129. Alle unter einem Dach: Erfolge und Herausforderungen auf dem Weg zu einer zentralisierten Biobank am Beispiel der BMBH
130. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics
131. Kapitel 34 - Gallenblase und extrahepatische Gallenwege
132. Kapitel 33 - Leber und intrahepatische Gallenwege
133. Erratum zu: Varianteninterpretation in dermolekularen Pathologie und Onkologie
134. Determining the reliability of liver biopsies in NASH clinical studies
135. HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
136. Association between serum IgG level and clinical course in primary sclerosing cholangitis
137. Nucleoporin Nup155 is part of the p53 network in liver cancer
138. Low frequency of mismatch repair deficiency in gallbladder cancer
139. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p
140. Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma
141. DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
142. Self-Assembly of Nanofilaments in Cyanobacteria for Protein Co-localization.
143. Nichtautonome Effekte des Onkogens YAP in der Hepatokarzinogenese
144. EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial
145. Progress of MCT Detector Technology at AIM Towards Smaller Pitch and Lower Dark Current
146. Simulation of Small-Pitch HgCdTe Photodetectors
147. Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
148. Author Correction: Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation
149. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition
150. Grundlagen der diagnostischen Beurteilung von Biopsie, Zytologie und Resektat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.